Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Totalis”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Ended earlyNCT04517864
What this trial is testing

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Who this might be right for
Alopecia Areata
Pfizer 71
Testing effectiveness (Phase 2)Study completedNCT03594227
What this trial is testing

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Who this might be right for
Alopecia
Aclaris Therapeutics, Inc. 87
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Post-approval studies (Phase 4)Study completedNCT01167946
What this trial is testing

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Who this might be right for
Alopecia TotalisAlopecia UniversalisOphiasic Alopecia
King Saud University 42
Not applicableStudy completedNCT05098600
What this trial is testing

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+24 more
Faculty Hospital Kralovske Vinohrady 123
Testing effectiveness (Phase 2)Study completedNCT03315689
What this trial is testing

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia Universalis (AU)Alopecia Totalis (AT)
Aclaris Therapeutics, Inc. 11
Large-scale testing (Phase 3)Study completedNCT00997815
What this trial is testing

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Who this might be right for
Recalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis
Siriraj Hospital 20
Large-scale testing (Phase 3)Study completedNCT00063076
What this trial is testing

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Who this might be right for
Alopecia Areata
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT03359356
What this trial is testing

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 60
Testing effectiveness (Phase 2)UnknownNCT04011748
What this trial is testing

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Throne Biotechnologies Inc. 20
Post-approval studies (Phase 4)Looking for participantsNCT07381556
What this trial is testing

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

Who this might be right for
Alopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more
Erasmus Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06747611
What this trial is testing

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
University of Minnesota 40
Large-scale testing (Phase 3)Study completedNCT04006457
What this trial is testing

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 1,057
Post-approval studies (Phase 4)Study completedNCT00176982
What this trial is testing

Plaquenil for Alopecia Areata, Alopecia Totalis

Who this might be right for
Alopecia Areata
Hordinsky, Maria K., MD 16
Testing effectiveness (Phase 2)Study completedNCT02197455
What this trial is testing

Tofacitnib for the Treatment of Alopecia Areata and Variants

Who this might be right for
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Yale University 30
Not applicableLooking for participantsNCT06283316
What this trial is testing

Systemic Treatments for Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+5 more
Erasmus Medical Center 10,000
Testing effectiveness (Phase 2)Study completedNCT02812342
What this trial is testing

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Yale University 10
Testing effectiveness (Phase 2)Ended earlyNCT03759340
What this trial is testing

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia AreataAlopecia UniversalisAlopecia Totalis
Aclaris Therapeutics, Inc. 56
Testing effectiveness (Phase 2)WithdrawnNCT03532958
What this trial is testing

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Equillium
Testing effectiveness (Phase 2)Study completedNCT03551821
What this trial is testing

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Aclaris Therapeutics, Inc. 1
Next Page